Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Exchange Rate Effect (2016 - 2017)

United Therapeutics (UTHR) has disclosed Exchange Rate Effect for 9 consecutive years, with -$200000.0 as the latest value for Q3 2017.

  • Quarterly Exchange Rate Effect rose 80.0% to -$200000.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Dec 2017, up 53.33% year-over-year, with the annual reading at $200000.0 for FY2017, 106.67% up from the prior year.
  • Exchange Rate Effect hit -$200000.0 in Q3 2017 for United Therapeutics, roughly flat from -$200000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.5 million in Q2 2015 to a low of -$3.1 million in Q1 2015.
  • Historically, Exchange Rate Effect has averaged -$742294.1 across 5 years, with a median of -$295000.0 in 2013.
  • Biggest YoY gain for Exchange Rate Effect was 374.68% in 2015; the steepest drop was 1912.99% in 2015.
  • Year by year, Exchange Rate Effect stood at -$295000.0 in 2013, then tumbled by 892.54% to -$2.9 million in 2014, then skyrocketed by 45.36% to -$1.6 million in 2015, then surged by 87.5% to -$200000.0 in 2016, then changed by 0.0% to -$200000.0 in 2017.
  • Business Quant data shows Exchange Rate Effect for UTHR at -$200000.0 in Q3 2017, -$200000.0 in Q4 2016, and -$1.0 million in Q3 2016.